Using prescription registries to define continuous drug use: How to fill gaps between prescriptions

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 4, 2008, Pages 384-388

  Nielsen, Lars Hougaard ^a,b   Løkkegaard, Ellen ^c   Andreasen, Anne Helms ^b   Keiding, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Research Centre for Prevention and Health   (Denmark)

^c Danish Centre for Human Reproductive Epidemiology   (Denmark)

Author keywords

Episodes of drug use; Gaps in treatment; Prescription registries; Survival analysis

Indexed keywords

ESTROGEN; GESTAGEN; SEX HORMONE;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; DENMARK; DRUG EXPOSURE; DRUG SAFETY; DRUG USE; DRUG UTILIZATION; DRUG WITHDRAWAL; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; MEDICAL RECORD; MENOPAUSAL SYNDROME; MORTALITY; PHARMACOEPIDEMIOLOGY; PHARMACY; POSTMENOPAUSE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT DURATION; FEMALE; METHODOLOGY; REGISTER; RETROSPECTIVE STUDY; STATISTICS;

DENMARK; DRUG UTILIZATION; FEMALE; HUMANS; PHARMACOEPIDEMIOLOGY; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 42149136283     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1549     Document Type: Article

References (13)

1. Strom BL. Pharmacoepidemiology, (4th edn). John Wiley & Sons: Chichester, New York, 2005.
2. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J clin Epidemiol 1997; 50(5): 619-625.
3. Olesen C, Sondergaard C, Thrane N, Nielsen GL, de Jong-Van den Berg LT, Olseen J. Do pregnant women report use of dispensed medications? Epidemiol 2001; 12(5): 497-501.
4. Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci 1991; 13(2): 91-96.
5. Løkkegaard EL, Johnsen SP, Heitmann BI, et al. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 2004; 83(5): 476-481.
6. Persson I, Bergkvist L, Adami HO. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol 1987; 16(2): 222-228.
7. Andersen PK, Borgan Ø, Gill RD, Keiding N. Statistical Models based on Counting Processes. Springer series in Statistics. Springer-Verlag: New York, 1993.
8. Schelleman H, Klungel OH, Witteman JC, et al. Diuretic-gene interaction and the risk of myocardial infarction and stroke. Parmacogenomics J 2007; 7(5): 346-352.
9. Hudson M, Huhues R, Pilote L. Parabolas of medication use and discontinuation after myocardial infarction - are we closing the treatment gap? Pharmacoepidemiol Drug Saf (in press) DOI:10.1002/ pds.
10. Sikka R, Fang X, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005; 11(7): 449-457.
11. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289(13): 1652-1658.
12. Juurlink DN, Mamdani M, Kopp A, Herrmann N, Laupacis A. A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin. Br J Clin Pharmacol 2005; 59(1): 102-107. DOI: 10.1111/ j.1365-2125.2005.02230.x.
13. Stroud LF, Mamdani M, Kopp A, Bell CM. The safety of levofloxacin in elderly patients on warfarin. Am j med 2005; 118(12): 1417.e7-1417.e12.